by
Astrid Fiano, DOTmed News Writer | May 13, 2009
The U.S. Food and Drug Administration (FDA) has announced that it will be holding a public workshop entitled "Implementation of Post-Approval Studies for Medical Devices." The FDA says the workshop's purpose is for discussion of issues related to post-approval studies of medical devices among interested parties.
The workshop is to be held in Silver Spring, MD at the FDA White Oak Campus, on June 4, 2009, from 9 a.m. to 5 p.m. and June 5, 2009, from 9 a.m. to 12 p.m. Anyone interested in registering to attend the workshop should do so by May 28, by e-mailing their name, title, organization affiliation, address, and e-mail contact information to Stephanie Zafonte at SZafonte(at)s-3.com. The workshop does not have a fee but does require advance registration and is first-come, first-serve for space.
According to the FDA's public notice, the agenda intends to include:

Ad Statistics
Times Displayed: 46052
Times Visited: 1302 Ampronix, a Top Master Distributor for Sony Medical, provides Sales, Service & Exchanges for Sony Surgical Displays, Printers, & More. Rely on Us for Expert Support Tailored to Your Needs. Email info@ampronix.com or Call 949-273-8000 for Premier Pricing.
--Regulatory requirements on implementation for a Post-Approval Study for medical devices;
--Challenges and successes in strategies for recruiting participants for Post-Approval Studies;
--Challenges and successes in the retention and compliance with follow-up requirements of participants for Post-Approval Studies;
--Using existing infrastructure such as national registries to facilitate Post-Approval Studies;
--Using innovative strategies to facilitate Post-Approval Studies;
--Clinical research organizations, industry, academia, and other clinical trial consultant perspectives on all prior issues related to implementing Post-Approval Studies for medical devices.
Information on the FDA's public meetings, including archives, is available at: http://www.fda.gov/cdrh/meetings.html.
Based on a Public Notice by the FDA accessed at the Government Printing Office website.